Company Name or Ticker Symbol
Search for other Categories

Aratana Therapeutics, Inc.  (PETX)
Other Ticker:  
    Sector  Healthcare    Industry Major Pharmaceutical Preparations

PETX's Revenue Year on Year Growth by Quarter and Year

Aratana Therapeutics,'s Revenue results by quarter and year

Select the Comparisons : Select the Ratio:                        
PETX Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 0.04 0.23 0.04
III Quarter September - 38.05 0.23 0.30
II Quarter June - 0.17 0.16 0.18
I Quarter March 3.80 0.06 0.25 -0.56
FY   3.80 38.32 0.87 -0.04

Financial Statements
Aratana Therapeutics,'s first quarter 2017 Revenue $ 3.80 millions PETX's Income Statement
Aratana Therapeutics,'s first quarter 2016 Revenue $ 0.06 millions Quarterly PETX's Income Statement
PETX's Growth by Division See PETX's Growth by Segment

PETX Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - -82.61 % 475 % -
III Quarter September - 16443.48 % -23.33 % -
II Quarter June - 6.25 % -11.11 % -
I Quarter March 6225 % -76 % - -
FY   - 4304.6 % - -

PETX Revenue Growth Comment
Aratana Therapeutics, Inc. achieved in the first quarter, above Company average Revenue surge of 6225% year on year, to $ 3.80 millions.

Looking into first quarter results within Major Pharmaceutical Preparations industry 4 other companies have achieved higher Revenue growth. While Aratana Therapeutics, Inc.' s Revenue doubling of 6225% ranks overall at the positon no. 36 in the first quarter.

Revenue Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #5
Healthcare Sector #10
S&P 500 #36
Revenue Y/Y Growth Statistics
High Average Low
16442.17 % 2349.94 % -82.53 %
(Jun 30 2016)   (Sep 30 2016)

You need to upgrade your Flash Player

Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PETX's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for PETX's Competitors
Revenue Growth for Aratana Therapeutics,'s Suppliers
Revenue Growth for PETX's Customers

You may also want to know
PETX's Annual Growth Rates PETX's Profitability Ratios PETX's Asset Turnover Ratio PETX's Dividend Growth
PETX's Roe PETX's Valuation Ratios PETX's Financial Strength Ratios PETX's Dividend Payout Ratio
PETX's Roa PETX's Inventory Turnover Ratio PETX's Growth Rates PETX's Dividend Comparisons

Companies with similar Revenue doubling for the quarter ending Mar 31 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2017
Fortress Biotech, Inc.  6,670.00 %$ 6,670.000 millions
Intercept Pharmaceuticals Inc  4,629.89 %$ 4,629.888 millions

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com